
NASDAQHealthcareMedical - Healthcare Information Services
Latest quote
$0.9766
+$0.0103 · +1.07%
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Regular session
$0.9766
+$0.0103 · +1.07%
Regular session · ET · Market data may be delayed.
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Day range
Current $0.9766
52-week range
Current $0.9766
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
47
Fair Value
Sentiment
63
Bullish
Risk
74
High Risk
Momentum
27
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales optimization, marketing initiatives, clinical research, new product creation, strategic planning, human capital acquisition, and the oversight of physician networks. Definitive Healthcare caters to a broad spectrum of clients, including biopharmaceutical firms, medical device manufacturers, healthcare information technology companies, and direct healthcare providers. Additionally, its clientele extends to diverse organizations within the wider healthcare ecosystem, such as staffing and commercial real estate companies, financial institutions, and other related entities. Founded in 2011, Definitive Healthcare Corp. is headquartered in Framingham, Massachusetts.
Day range
Current $0.9766
52-week range
Current $0.9766
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 241.52M USD | 252.2M USD | 251.42M USD | 222.65M USD | 166.15M USD |
| Cost of goods sold | 58.25M USD | 54.73M USD | 47.48M USD | 42.63M USD | 40.69M USD |
| Gross profit | 183.28M USD | 197.47M USD | 203.93M USD | 180.03M USD | 125.47M USD |
| Research and development | 34.78M USD | 36.52M USD | 42.44M USD | 34.89M USD | 18.57M USD |
| Selling, general, and administrative | 133.26M USD | 133.07M USD | 153.4M USD | 141.15M USD | 89.25M USD |
| Operating expenses | 203.86M USD | 908.29M USD | 533.73M USD | 224.07M USD | 152.78M USD |
| Interest income | 6.95M USD | 14.59M USD | 13.64M USD | 2.79M USD | 29K USD |
| Interest expense | 11.29M USD | 14.84M USD | 15.2M USD | 11.2M USD | 25.9M USD |
| Depreciation and amortization | 56.11M USD | 51.67M USD | 51.75M USD | 56.9M USD | 59.95M USD |
| Operating income | −20.58M USD | −710.82M USD | −329.8M USD | −44.04M USD | −27.32M USD |
| Net income | −138.93M USD | −413.12M USD | −202.39M USD | −7.22M USD | −51.91M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI1.26M0.00%2.3T USD0.03%$382.05+0.66%
Dimensional - US Small Cap ETFDFAS616.12K0.00%33.8B USD0.31%$78.46+0.46%
Vanguard Extended Market ETFVXF453.78K0.00%95.4B USD0.05%$235.09+0.84%
U.S. Micro Cap Portfolio ETFDFMC266.66K0.00%7.54B USD0.43%$57.87+0.29%
Dimensional - US Core Equity 2 ETFDFAC198.23K0.00%88.2B USD0.21%$45.345+0.52%
WisdomTree U.S. SmallCap FundEES113.29K0.02%683.92M USD0.38%$65.51+0.11%
iShares Micro-Cap ETFIWC111.98K0.01%1.32B USD0.60%$183.1+0.17%
Invesco RAFI US 1500 Small-Mid ETFPRFZ68.74K0.00%2.65B USD0.36%$53.23+0.78%
Vanguard Morningstar Total Stock Market ETFVTI
Dimensional - US Small Cap ETFDFAS
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
Dimensional - US Core Equity 2 ETFDFAC
WisdomTree U.S. SmallCap FundEES
iShares Micro-Cap ETFIWC
Invesco RAFI US 1500 Small-Mid ETFPRFZAI-generated and delayed market data for informational and educational purposes only. Not investment advice.